Home CONTACT Bratislava Medical Journal 2018 Bratislava Medical Journal Vol.119, No.6, p.341-347, 2018

Journal info


 


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.564

 

Aims and Scope
Editorial Info
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.119, No.6, p.341-347, 2018

Title: MicroRNAs in pathophysiology of acute myocardial infarction and cardiogenic shock
Author: M. Pavkova Goldbergova, J. Lipkova, J. Fedorko, J. Sevcikova, J. Parenica, J. Spinar, M. Masarik, A. Vasku
Abstract: AIM: Levels of circulating miRNA are considered to be potential biomarkers of acute myocardial infarction and disease progression.
METHODS: In this study, the expression levels of circulating miRNA-1, miRNA-133 and miRNA-124a were investigated in a group of patients with acute myocardial infarction (STEMI) and cardiogenic shock (CS) compared to controls.
RESULTS: During the hospitalization period, miRNA-133 showed a significant up-regulation in the serum of STEMI and CS patients compared to controls, while the expression of miRNA-1 was significantly different only in CS. The expression of miRNA-124 was significantly higher in STEMI and CS. Furthermore, miRNA-1 expression was related to the level of circulating glucose in patients with STEMI. We also found a negative correlation between miRNA-133 and MMP-9 levels. MiRNA-124 expression was significantly related to the level of soluble ST2; the marker correlated to cardiac damage.
CONCLUSION: All selected miRNAs are potential markers of cardiac injury in cardiogenic shock, whereas miRNA-124a and -133 are markers of injury in STEMI. MiRNA-1 expression is related to circulating glucose in STEMI. None of miRNAs could be correlated to the extent of injury, progress of the disease, or prognosis of patient outcome. Therefore, the levels of circulating miRNA have no potential for becoming a biomarker of myocardial damage and as such would bring no further benefit compared to current markers (Tab. 4, Fig. 1, Ref. 47).
Keywords: microRNA, STEMI, cardiogenic shock, prognosis
Published online: 27-Jun-2018
Year: 2018, Volume: 119, Issue: 6 Page From: 341, Page To: 347
doi:10.4149/BLL_2018_064


download file


© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.